Relaxin family peptides: structure-activity relationship studies

Area of Science:

• Endocrinology
• Pharmacology
• Molecular Biology

Background:

• The human relaxin peptide family comprises seven cystine-rich peptides.
• Four members signal through relaxin family peptide receptors (RXFP1-4).
• These peptides are physiologically important and implicated in various diseases, making them targets for drug discovery.

Purpose of the Study:

• To review current knowledge on the structure-activity relationships (SAR) of key human relaxin family peptides.
• To consolidate findings from SAR studies for human relaxin 2 (H2 relaxin), human relaxin 3 (H3 relaxin), human insulin-like peptide 3 (INSL3), and human insulin-like peptide 5 (INSL5).

Main Methods:

• Literature review of published structure-activity relationship (SAR) studies.
• Focus on studies detailing the role of specific amino acid residues.
• Synthesis of information regarding peptide design for antagonists and minimized agonists.

Main Results:

• Detailed SAR studies have elucidated the function of critical residues in H2 relaxin, H3 relaxin, INSL3, and INSL5.
• This knowledge has been instrumental in designing peptide-based therapeutics.
• Antagonists and minimized agonist variants have been developed based on SAR findings.

Conclusions:

• A comprehensive understanding of SAR for these relaxin family peptides is vital for advancing drug discovery.
• Continued SAR investigation will facilitate the development of more targeted and effective peptide therapeutics.
• This review serves as a resource for researchers in the field of relaxin peptide pharmacology.